Home > Insider Trading > Filing (0001645113-22-000023)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645113	Novocure Ltd	NVCR	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1693530	Christopher Todd Longsworth	C/O Novocure Inc. 20 Valley Stream Parkway, Suite 300 Malvern PA 19355	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2022-03-03	1,094	$74.50	66,774	No	4	S	Direct
Ordinary Shares	Disposition	2022-03-04	1,973	$70.41	64,801	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Options to Buy Ordinary Shares	Acquisiton	2022-03-03	6,106	$80.59	6,106	$80.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,106	2023-03-01	2032-02-29	No	4	A	Direct

Footnotes

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Options to buy 6,106 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.